Безопасен ли baicalin при беременности?
No harmonised CLP reproductive classification (no H360/H361) and no SCCS/CIR safety assessment flagging reproductive hazard were identified. PubMed/PMC studies of baicalin in pregnancy models report pharmacologic/modulatory effects (some protective in LPS models) rather than consistent reproductive toxicity, so by source-priority standards there is no evidence requiring a hazard flag. Sources: PubMed/PMC animal studies and regulatory databases (PubChem/KEGG, EWG).
Pregnancy-safe products containing baicalin










Related ingredients
Frequently asked questions
- Безопасен ли baicalin при беременности?
- No harmonised CLP reproductive classification (no H360/H361) and no SCCS/CIR safety assessment flagging reproductive hazard were identified. PubMed/PMC studies of baicalin in pregnancy models report pharmacologic/modulatory effects (some protective in LPS models) rather than consistent reproductive toxicity, so by source-priority standards there is no evidence requiring a hazard flag. Sources: PubMed/PMC animal studies and regulatory databases (PubChem/KEGG, EWG).
- Безопасен ли baicalin при грудном вскармливании?
- No regulatory or authoritative safety assessment (CIR, SCCS, harmonised CLP) indicates lactation/transfer hazards, and published studies do not provide clear evidence of adverse effects via lactation. No data found demonstrating transfer in human milk or adverse pup outcomes via lactation in relevant high-quality studies; therefore default score is 0. (See cited studies and database entries.)
- Безопасен ли baicalin для кожи малыша?
- No evidence of a reproductive/developmental hazard specific to infants (h=0). Mechanistic evidence for a reproductive mechanism was not identified (m=0). For exposure (e) I increased the score by +1 for baby skin because baicalin is a small natural flavonoid glycoside with measurable biological activity in vivo (so it is not completely non‑absorbable); topical dermal absorption from cosmetics is expected to be low for the parent compound but infant skin has a higher surface‑area‑to‑weight and immature barrier, so exposure for 0–3 y is assigned 1. No infant‑specific toxicokinetic data were found to justify higher exposure or hazard scores.
- Как VeriMom оценивает baicalin?
- VeriMom оценивает baicalin в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы baicalin при беременности?
- См. наш список безопасных альтернатив baicalin с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.